ESTERASE SENSITIVE MOTIF

Trademark usage description

chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, i Read More

Classification Information

Class [005]
Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic diseases, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic diseases, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease.

Classification kind code

Class [042]
Pharmaceutical research and development services; scientific research in the fields of oncology, immuno-oncology, immunotherapy, metabolic diseases, skin diseases, viral diseases, hormonal related diseases, musculoskeletal diseases, and neurological diseases and information, advisory and consultancy services relating to the aforesaid.

Classification kind code

Mark Details

Serial Number

1835466

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 20^th Jun 2019	Agent Changed
Submitted for opposition 26 on 6^th Jun 2019	Approved
Submitted for opposition 27 on 17^th Apr 2019	Approval Notice Sent
Submitted for opposition 15 on 15^th Mar 2019	Correspondence Created
Submitted for opposition 12 on 15^th Nov 2018	Extension of Time
Submitted for opposition 22 on 3^rd May 2018	Search Recorded
Submitted for opposition 20 on 3^rd May 2018	Examiner's First Report
Submitted for opposition 31 on 10^th May 2017	Formalized
Submitted for opposition 1 on 3^rd May 2017	Created
Submitted for opposition 30 on 2^th May 2017	Filed